サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702053

麻酔・呼吸器デバイス市場レポート：製品タイプ別、エンドユーザー別、地域別、2025年～2033年

Anesthesia and Respiratory Devices Market Report by Product Type, End User, Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 142 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
麻酔・呼吸器デバイス市場レポート：製品タイプ別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

麻酔・呼吸器デバイス市場の世界市場規模は2024年に497億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに854億米ドルに達し、2025～2033年の成長率（CAGR）は5.88％になると予測しています。呼吸器疾患の有病率の上昇、外科手術の増加、高齢化人口の拡大、ヘルスケアとインフラ整備の進展、政府の積極的な取り組みと医療支出などが市場を後押しする主な要因です。

麻酔・呼吸器デバイスは、外科手術中の患者ケアを容易にし、呼吸器疾患を管理するためにヘルスケア環境で使用される必須医療機器です。麻酔装置は、患者に全身麻酔を施し、一時的に感覚と意識を失わせ、痛みのない手術を可能にするように設計されています。これらの装置には通常、麻酔器、気化器、および患者の安全性と適切な投与量を確保するためのさまざまな監視装置が含まれます。一方、呼吸器は呼吸器疾患の治療や管理に用いられる医療器具です。慢性閉塞性肺疾患（COPD）、喘息、急性呼吸窮迫症候群（ARDS）などの患者の呼吸と酸素供給を改善するのに役立ちます。一般的な呼吸器には、人工呼吸器、持続陽圧呼吸器（CPAP）、ネブライザー、酸素濃縮器などがあります。人工呼吸器は、自力で十分な呼吸ができない患者に機械的換気のサポートを提供する上で特に重要です。麻酔・呼吸器デバイスも、現代のヘルスケアにおいて重要な役割を果たしており、患者の転帰を向上させ、医療全体を改善しています。これらの機器は、安全性、有効性、品質を確保するために厳しい規制要件が課されており、その継続的な開発と技術革新は、医療行為と患者の福祉の向上に大きく貢献しています。

慢性閉塞性肺疾患（COPD）、喘息、睡眠時無呼吸症候群を含む呼吸器疾患の罹患率の上昇は、呼吸器用機器の主要な原動力です。これらの疾患は継続的なモニタリングと管理を必要とするため、酸素濃縮器、ネブライザー、CPAPマシンなどの呼吸器機器の需要が増加しています。さらに、世界人口の増加とヘルスケア・サービスへのアクセス向上が相まって、外科手術の急増につながっています。麻酔装置は、手術中の安全かつ効果的な麻酔投与を確保するために不可欠であり、麻酔装置、人工呼吸器、および関連機器の需要を煽っています。このほか、高齢化社会への人口動態の変化は、慢性疾患や呼吸器疾患の有病率の上昇に寄与しています。高齢者は医療介入、手術、呼吸器サポートを必要とすることが多く、麻酔・呼吸器デバイスの需要を牽引しています。このほか、特に新興国ではヘルスケア・インフラの拡大により、病院や専門クリニックなどの医療施設への投資が増加しています。このようなヘルスケア施設の増加は、より多くの患者のニーズに応えるため、麻酔・呼吸器機器の需要を強化しています。さらに、政府の支援政策、ヘルスケアへの投資、治療への保険適用が、麻酔・呼吸器市場の成長をさらに刺激し、これらの機器の採用率を高めています。さらに、医療技術の継続的な進歩により、より洗練された使いやすい麻酔・呼吸器デバイスの開発が進んでいます。患者モニタリング機能を向上させた先進的な人工呼吸器、精度と安全性を高めた麻酔器、携帯型呼吸器などの技術革新により、これらの機器の採用と需要が増加しています。

麻酔・呼吸器デバイス市場動向/促進要因：

技術の進歩

技術の進歩は、機能を強化した革新的な機器を導入することで、麻酔・呼吸器市場に革命をもたらしました。例えば、先進的な麻酔器は現在、統合タッチスクリーンインターフェース、リアルタイムデータ監視、自動薬物送達システムを提供し、手術中の精度と患者の安全性を向上させています。同様に呼吸器用機器も目覚ましい進歩を遂げており、携帯型酸素濃縮器によって、患者は酸素療法を継続的に受けながら移動能力を維持できるようになりました。さらに、高度なアルゴリズムを搭載したスマート人工呼吸器は、変化する患者の呼吸ニーズに適応し、個別化されたケアを提供することができます。こうした技術改良は、麻酔・呼吸器治療の効率と有効性を高めるだけでなく、患者の転帰の改善と回復時間の短縮にも貢献し、ヘルスケアプロバイダーによるこれらの機器の採用を世界的に促進しています。

呼吸器疾患の有病率の上昇

呼吸器疾患の有病率の上昇は、麻酔・呼吸器市場に大きな影響を与えています。COPD、喘息、睡眠時無呼吸症候群などの慢性呼吸器疾患は、世界中で数百万人に影響を及ぼしています。その結果、これらの慢性疾患を効果的に管理するために、ネブライザー、CPAPマシン、BiPAPマシンなどの呼吸器系機器の需要が急増しています。さらに、環境要因、汚染、ライフスタイルの変化が呼吸器疾患患者数の増加に寄与しており、市場の成長をさらに促進しています。メーカーは、患者の快適性を向上させ、より良い疾患管理を提供する先進的な呼吸器デバイスを開発するために研究開発に投資しており、このようなソリューションに対する需要の高まりに対応しています。

高齢化人口の拡大

世界人口の高齢化は、麻酔・呼吸器市場の主要な促進要因です。高齢者の増加に伴い、呼吸器疾患を含む加齢に関連した健康問題の有病率が上昇しています。高齢者は外科手術を必要とすることが多く、安全で正確な麻酔を提供するための麻酔器に対する需要が高まっています。さらに、高齢者は呼吸器系の病気にかかりやすいため、その健康状態を管理するための人工呼吸器や酸素濃縮器などの呼吸器系機器のニーズが高まっています。政府やヘルスケアプロバイダーは、高齢化社会の医療ニーズに対応するために医療施設の更新に投資しており、麻酔・呼吸器機器の需要をさらに押し上げています。この人口動態の変化は、今後数年間、市場の成長軌道を維持すると予想されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の麻酔・呼吸器デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 麻酔器具
    • 主要セグメント
      • 麻酔導入装置
      • 麻酔用使い捨て器具および付属品
      • 麻酔モニター
      • 麻酔情報管理システム
  • 呼吸器系デバイス
    • 主要セグメント
      • 治療機器
      • マスク
      • 人工呼吸器
      • ネブライザー
      • 加湿器
      • 酸素濃縮器
      • 吸入器
      • 再利用可能な蘇生器
      • 一酸化窒素送達ユニット
      • カプノグラフ
      • ガス分析装置
      • 酸素フード
  • 監視デバイス
  • 診断装置
    • 主要セグメント
      • スパイロメーター
      • 睡眠ポリグラフ検査（PSG）装置
      • ピークフローメーター
  • 消耗品とアクセサリー
    • 主要セグメント
      • 使い捨て蘇生器
      • 気管切開チューブ
      • 鼻カニューラ
      • 使い捨てマスク
      • その他

第7章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • 在宅ケア設定
  • 外来サービスセンター

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Becton, Dickinson and Company
    • Dragerwerk AG & Co. KGaA
    • Fisher & Paykel Healthcare Corporation Limited
    • GE HealthCare（General Electric）
    • Getinge AB
    • Hamilton Medical（Hamilton Bonaduz AG）
    • ICU Medical Inc.
    • Koninklijke Philips N.V.
    • Masimo Corporation
    • Medtronic plc
    • SunMed LLC
    • Teleflex Incorporated
図表

List of Figures

  • Figure 1: Global: Anesthesia and Respiratory Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Anesthesia and Respiratory Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Anesthesia and Respiratory Devices Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Anesthesia and Respiratory Devices Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Anesthesia and Respiratory Devices Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Anesthesia and Respiratory Devices (Anesthesia Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Anesthesia and Respiratory Devices (Anesthesia Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Anesthesia and Respiratory Devices (Respiratory Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Anesthesia and Respiratory Devices (Respiratory Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Anesthesia and Respiratory Devices (Monitoring Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Anesthesia and Respiratory Devices (Monitoring Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Anesthesia and Respiratory Devices (Diagnostic Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Anesthesia and Respiratory Devices (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Anesthesia and Respiratory Devices (Consumables and Accessories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Anesthesia and Respiratory Devices (Consumables and Accessories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Anesthesia and Respiratory Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Anesthesia and Respiratory Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Anesthesia and Respiratory Devices (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Anesthesia and Respiratory Devices (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Anesthesia and Respiratory Devices (Homecare Settings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Anesthesia and Respiratory Devices (Homecare Settings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Anesthesia and Respiratory Devices (Ambulatory Service Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Anesthesia and Respiratory Devices (Ambulatory Service Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: North America: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: North America: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: United States: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: United States: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Canada: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Canada: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Asia-Pacific: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Asia-Pacific: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: China: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: China: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Japan: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Japan: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: India: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: India: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: South Korea: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: South Korea: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Australia: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Australia: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Indonesia: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Indonesia: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Others: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Others: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Europe: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Europe: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Germany: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Germany: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: France: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: France: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: United Kingdom: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: United Kingdom: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Italy: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Italy: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Spain: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Spain: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Russia: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Russia: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Latin America: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Latin America: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Brazil: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Brazil: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Mexico: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Mexico: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Middle East and Africa: Anesthesia and Respiratory Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Middle East and Africa: Anesthesia and Respiratory Devices Market: Breakup by Country (in %), 2024
  • Figure 73: Middle East and Africa: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Global: Anesthesia and Respiratory Devices Industry: SWOT Analysis
  • Figure 75: Global: Anesthesia and Respiratory Devices Industry: Value Chain Analysis
  • Figure 76: Global: Anesthesia and Respiratory Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anesthesia and Respiratory Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anesthesia and Respiratory Devices Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Anesthesia and Respiratory Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Anesthesia and Respiratory Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Anesthesia and Respiratory Devices Market: Competitive Structure
  • Table 6: Global: Anesthesia and Respiratory Devices Market: Key Players
目次
Product Code: SR112025A6105

The global anesthesia and respiratory devices market size reached USD 49.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 85.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.88% during 2025-2033. The rising prevalence of respiratory disorders, increasing surgical procedures, expanding aging population, growing healthcare and infrastructure development, and favorable government initiatives and healthcare spending are some of the major factors propelling the market.

Anesthesia and respiratory devices are essential medical equipment used in healthcare settings to facilitate patient care during surgical procedures and manage respiratory conditions. Anesthesia devices are designed to administer general anesthesia to patients, inducing temporary loss of sensation and consciousness, enabling painless surgery. These devices typically include anesthesia machines, vaporizers, and various monitoring equipment to ensure patient safety and appropriate dosage administration. On the other hand, respiratory devices are medical tools utilized in the treatment and management of respiratory disorders. They aid in improving breathing and oxygenation for patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, or acute respiratory distress syndrome (ARDS). Some common respiratory devices include ventilators, continuous positive airway pressure (CPAP) machines, nebulizers, and oxygen concentrators. Ventilators are especially crucial in providing mechanical ventilation support to patients who are unable to breathe adequately on their own. Both anesthesia and respiratory devices play vital roles in modern healthcare, enhancing patient outcomes and improving overall medical care. These devices are subject to stringent regulatory requirements to ensure their safety, efficacy, and quality, and their continuous development and innovation contribute significantly to advancing medical practices and patient well-being.

The rising incidence of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is a major driver for respiratory devices. These conditions require ongoing monitoring and management, leading to an increased demand for respiratory equipment like oxygen concentrators, nebulizers, and CPAP machines. Additionally, the growing global population, coupled with improved access to healthcare services, has led to a surge in surgical procedures. Anesthesia devices are crucial for ensuring safe and effective anesthesia administration during surgeries, fueling the demand for anesthesia machines, ventilators, and associated equipment. Other than this, the demographic shift towards an aging population has contributed to the rising prevalence of chronic diseases and respiratory disorders. Older adults often require medical interventions, surgeries, and respiratory support, driving the demand for anesthesia and respiratory devices. Besides this, expanding healthcare infrastructure, particularly in emerging economies, has led to increased investments in medical facilities, including hospitals and specialty clinics. This growth in healthcare facilities has bolstered the demand for anesthesia and respiratory equipment to cater to the needs of a larger patient population. Moreover, supportive government policies, investments in healthcare, and insurance coverage for medical treatments have further stimulated the growth of the anesthesia and respiratory market, encouraging higher adoption rates of these devices. Moreover, continuous advancements in medical technology have led to the development of more sophisticated and user-friendly anesthesia and respiratory devices. Innovations such as advanced ventilators with improved patient monitoring capabilities, anesthesia machines with enhanced precision and safety features, and portable respiratory devices have increased their adoption and demand.

Anesthesia and Respiratory Devices Market Trends/Drivers:

Technological Advancements

Technological advancements have revolutionized the anesthesia and respiratory market by introducing innovative devices with enhanced capabilities. For instance, advanced anesthesia machines now offer integrated touchscreen interfaces, real-time data monitoring, and automated drug delivery systems, improving precision and patient safety during surgery. Similarly, respiratory devices have seen remarkable progress, with portable oxygen concentrators enabling patients to maintain mobility while receiving continuous oxygen therapy. Additionally, smart ventilators equipped with advanced algorithms can adapt to patients' changing respiratory needs, providing personalized care. These technological improvements not only enhance the efficiency and efficacy of anesthesia and respiratory treatments but also contribute to better patient outcomes and reduced recovery times, driving the adoption of these devices by healthcare providers globally.

Rising Prevalence of Respiratory Disorders

The escalating prevalence of respiratory disorders has significantly impacted the anesthesia and respiratory market. Chronic respiratory conditions like COPD, asthma, and sleep apnea affect millions of people worldwide. Consequently, the demand for respiratory devices such as nebulizers, CPAP machines, and BiPAP machines has surged to manage these chronic conditions effectively. Moreover, environmental factors, pollution, and lifestyle changes have contributed to an increase in the number of respiratory disorder cases, further fueling the market's growth. Manufacturers are investing in research and development to create advanced respiratory devices that offer improved patient comfort and better disease management, catering to the escalating demand for such solutions.

Expanding Aging Population

The aging global population is a key driver of the anesthesia and respiratory market. With a higher number of elderly individuals, the prevalence of age-related health issues, including respiratory diseases, has risen. Older adults often require surgical interventions, leading to an increased demand for anesthesia machines to provide safe and precise anesthesia delivery. Furthermore, as the elderly are more susceptible to respiratory illnesses, there is a growing need for respiratory devices like ventilators and oxygen concentrators to manage their health conditions. Governments and healthcare providers are investing in updating their medical facilities to accommodate the aging population's healthcare needs, further propelling the demand for anesthesia and respiratory equipment. This demographic shift is expected to sustain the market's growth trajectory in the coming years.

Anesthesia and Respiratory Devices Industry Segmentation:

Breakup by Product Type:

  • Anesthesia Devices
  • Anesthesia Delivery Machines
  • Anesthesia Disposables and Accessories
  • Anesthesia Monitors
  • Anesthesia Information Management Systems
  • Respiratory Devices
  • Therapeutic Devices
  • Masks
  • Ventilators
  • Nebulizers
  • Humidifiers
  • Oxygen Concentrators
  • Inhalers
  • Reusable Resuscitators
  • Nitric Oxide Delivery Units
  • Capnographs
  • Gas Analyzers
  • Oxygen Hoods
  • Monitoring Devices
  • Diagnostic Devices
  • Spirometers
  • Polysomnography (PSG) Devices
  • Peak Flow Meters
  • Consumables and Accessories
  • Disposable Resuscitators
  • Tracheostomy Tubes
  • Nasal Cannulas
  • Disposable Masks
  • Others

Respiratory devices dominate the market

The rising prevalence of respiratory disorders globally has significantly increased the demand for respiratory devices. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea affect a large portion of the population, necessitating continuous monitoring and treatment, thereby boosting the market for respiratory devices. Additionally, advancements in medical technology have led to the development of more sophisticated and efficient respiratory devices. These innovations have improved patient comfort, ease of use, and treatment outcomes, driving healthcare providers to adopt the latest respiratory equipment, further contributing to the segment's growth. Other than this, with the aging population on the rise, the incidence of respiratory diseases is also increasing. Older adults are more susceptible to respiratory conditions, requiring respiratory devices for proper disease management and oxygen support. This demographic trend has significantly expanded the market for respiratory devices. Moreover, the ongoing COVID-19 pandemic has further accelerated the demand for respiratory devices like ventilators to provide life-saving respiratory support for critically ill patients, underscoring the critical role these devices play in managing respiratory distress.

Breakup by End User:

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Service Centers

Hospitals hold the largest share in the market

Hospitals serve as primary centers for providing advanced medical care, including surgeries, critical care, and specialized treatments. These medical facilities require a wide array of anesthesia and respiratory devices to cater to the diverse needs of patients across various medical disciplines. From anesthesia machines for surgical procedures to ventilators for patients in intensive care units, hospitals rely heavily on these devices to ensure optimal patient outcomes. Additionally, hospitals typically have a high patient throughput, admitting a large number of individuals requiring medical attention daily. This consistent flow of patients necessitates a substantial demand for anesthesia and respiratory devices to support their medical needs, contributing to the segment's size. Other than this, hospitals often have well-established budgets for medical equipment procurement, allowing them to invest in modern and technologically advanced anesthesia and respiratory devices. These devices play a critical role in enhancing patient care, leading hospitals to prioritize their acquisition. Furthermore, the ongoing pandemic situations, like COVID-19, have emphasized the need for well-equipped hospitals with an adequate supply of respiratory devices like ventilators to manage respiratory distress in critically ill patients. This further reinforces the hospitals' significance as the largest end-user segment in the anesthesia and respiratory market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anesthesia and respiratory devices.

North America has a well-established and advanced healthcare infrastructure, with a high number of hospitals, specialty clinics, and medical facilities. This extensive healthcare network leads to a significant demand for anesthesia and respiratory devices to support the diverse medical needs of patients. Additionally, the region has a substantial elderly population, and with aging comes an increased prevalence of respiratory conditions and the need for surgical interventions, further driving the demand for these devices. Moreover, the region's strong emphasis on research and development in the medical technology sector has led to continuous innovation and the introduction of cutting-edge anesthesia and respiratory devices. This culture of technological advancement and early adoption of new medical equipment contributes to the market's growth. Besides this, factors such as favorable government initiatives, high healthcare expenditure, and insurance coverage facilitate greater accessibility to advanced medical treatments, including anesthesia and respiratory care, further propelling the market in North America. Furthermore, the outbreak of global health crises, such as the COVID-19 pandemic, has highlighted the critical importance of having a robust supply of respiratory devices like ventilators, elevating the demand for these devices in the region.

Competitive Landscape:

Leading companies in the anesthesia and respiratory devices market invest significantly in research and development to introduce innovative products with advanced features. These innovations aim to improve patient outcomes, enhance user experience, and address specific medical challenges. For example, companies may develop anesthesia machines with integrated patient monitoring systems, smart ventilation modes, or respiratory devices with better portability and user-friendly interfaces. By continuously introducing cutting-edge technologies, key players can attract more customers, gain a competitive edge, and drive market growth. Additionally, collaborations and partnerships with other healthcare companies, research institutions, or technology firms are common strategies employed by key players in the anesthesia and respiratory devices market. These partnerships facilitate the exchange of knowledge, expertise, and resources, leading to the development of innovative solutions. For instance, a medical device manufacturer may collaborate with a software company to integrate artificial intelligence algorithms into their devices for enhanced diagnostics and personalized treatments. Such strategic alliances enable companies to leverage each other's strengths and expand their product portfolio, leading to increased market presence and revenue growth. Other than this, in order to tap into emerging markets and cater to the growing demand for anesthesia and respiratory devices, key players often focus on expanding their geographic reach. This expansion may involve establishing new distribution channels, setting up local manufacturing facilities, or acquiring regional companies to gain a foothold in specific markets. By penetrating new regions, companies can access a larger customer base, better understand local requirements, and adapt their products to meet diverse healthcare needs, ultimately driving market growth.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • 3M Company
  • Becton, Dickinson and Company
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Corporation Limited
  • GE HealthCare (General Electric)
  • Getinge AB
  • Hamilton Medical (Hamilton Bonaduz AG)
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • SunMed LLC
  • Teleflex Incorporated

Key Questions Answered in This Report

  • 1.What was the size of the anesthesia and respiratory devices market in 2024?
  • 2.What is the expected growth rate of the global anesthesia and respiratory devices market during 2025-2033?
  • 3.What are the key factors driving the global anesthesia and respiratory devices market?
  • 4.What has been the impact of COVID-19 on the global anesthesia and respiratory devices market?
  • 5.What is the breakup of the global anesthesia and respiratory devices market based on the product type?
  • 6.What is the breakup of the global anesthesia and respiratory devices market based on the end user?
  • 7.What are the key regions in the global anesthesia and respiratory devices market?
  • 8.Who are the key players/companies in the global anesthesia and respiratory devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anesthesia and Respiratory Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Anesthesia Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anesthesia Delivery Machines
      • 6.1.2.2 Anesthesia Disposables and Accessories
      • 6.1.2.3 Anesthesia Monitors
      • 6.1.2.4 Anesthesia Information Management Systems
    • 6.1.3 Market Forecast
  • 6.2 Respiratory Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Therapeutic Devices
      • 6.2.2.2 Masks
      • 6.2.2.3 Ventilators
      • 6.2.2.4 Nebulizers
      • 6.2.2.5 Humidifiers
      • 6.2.2.6 Oxygen Concentrators
      • 6.2.2.7 Inhalers
      • 6.2.2.8 Reusable Resuscitators
      • 6.2.2.9 Nitric Oxide Delivery Units
      • 6.2.2.10 Capnographs
      • 6.2.2.11 Gas Analyzers
      • 6.2.2.12 Oxygen Hoods
    • 6.2.3 Market Forecast
  • 6.3 Monitoring Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostic Devices
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Spirometers
      • 6.4.2.2 Polysomnography (PSG) Devices
      • 6.4.2.3 Peak Flow Meters
    • 6.4.3 Market Forecast
  • 6.5 Consumables and Accessories
    • 6.5.1 Market Trends
    • 6.5.2 Key Segments
      • 6.5.2.1 Disposable Resuscitators
      • 6.5.2.2 Tracheostomy Tubes
      • 6.5.2.3 Nasal Cannulas
      • 6.5.2.4 Disposable Masks
      • 6.5.2.5 Others
    • 6.5.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Homecare Settings
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Ambulatory Service Centers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Dragerwerk AG & Co. KGaA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Fisher & Paykel Healthcare Corporation Limited
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 GE HealthCare (General Electric)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Getinge AB
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Hamilton Medical (Hamilton Bonaduz AG)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 ICU Medical Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Masimo Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Medtronic plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 SunMed LLC
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
    • 13.3.13 Teleflex Incorporated
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio